Tanna Shaw
Internal Medicine · Edmond, OKNPI 1962430363
Payments from drug & device makers
Across 192 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$712
- Amgen$624
- Novo Nordisk$403
- Lilly USA, LLC$259
- Eisai Inc.$240
- GSK$207
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $712 |
| Amgen | 22 | $624 |
| Novo Nordisk | 17 | $403 |
| Lilly USA, LLC | 15 | $259 |
| Eisai Inc. | 7 | $240 |
| GSK | 13 | $207 |
| Corcept Therapeutics | 9 | $187 |
| Bayer | 7 | $146 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $140 |
| Kyowa Kirin, Inc. | 2 | $137 |
| Pfizer | 7 | $128 |
| Axsome Therapeutics, Inc. | 5 | $114 |
| Boehringer Ingelheim | 5 | $97 |
| Organon | 3 | $69 |
| AstraZeneca | 4 | $66 |
| Kowa Pharmaceuticals America, Inc. | 3 | $54 |
| Biogen | 2 | $47 |
| Merck | 3 | $45 |
| Currax Pharmaceuticals LLC | 3 | $42 |
| Antares Pharma, Inc. | 2 | $39 |
| Exact Sciences | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 1 | $37 |
| Abbott | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| La Jolla Pharmaceutical Company | 1 | $27 |
| Nevro Corp. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Novartis | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Halozyme Inc | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOURIANZ$117
- Otezla$116
- NURTEC ODT$109
- Prolia$101
- Leqembi$101
How this compares
$4,228 in reported general payments places this provider in the 85th percentile of 840 internal medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $45,905 |
| TrulicityDulaglutide | 20 | $28,034 |
| JardianceEmpagliflozin | 13 | $20,617 |
| Repatha SureclickEvolocumab | 13 | $10,678 |
| UbrelvyUbrogepant | 15 | $10,510 |
| Ezetimibe | 29 | $1,773 |
| Estradiol | 22 | $1,057 |
| ProgesteroneProgesterone, Micronized | 18 | $1,020 |
| Celecoxib | 11 | $953 |
| Rosuvastatin Calcium | 34 | $857 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $777 |
| Levothyroxine Sodium | 55 | $633 |
| Duloxetine Hcl | 15 | $616 |
| Pilocarpine Hcl | 17 | $493 |
| Ibandronate Sodium | 14 | $422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $259 | $73,94064 claims |
| Boehringer IngelheimJardiance | $97 | $20,61713 claims |
| AbbVieUbrelvy | $712 | $10,51015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Edmond
- Todd KrehbielEdmond$21K
- Ashlee WaughEdmond$15K
- William MorganEdmond$13K
- Thomas KupiecEdmond$12K
- Al-Ola AbdallahTulsa$10.1M
- Melita TateTulsa$9.1M
- Sagila GeorgeOklahoma City$1.8M
- Ryan MorganOklahoma City$775K
- Renae MayerTulsa$766K
- George FreemanIdabel$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.